Chemical Compound

TSU-68; 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic Acid; 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone; 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; NSC 702827; Orantinib; SU 6668;

CAS Registry Number 252916-29-3
返回搜索 申请报价
TSU-68; 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic Acid; 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone; 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; NSC 702827; Orantinib; SU 6668; 结构式
Primary record

TSU-68; 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic Acid; 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone; 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; NSC 702827; Orantinib; SU 6668;

库存
2,220 克
纯度
99.5 %
CAS
252916-29-3

化合物标识与属性

CAS
252916-29-3
PubChem CID
5329099
SMILES
CC1=C(NC(=C1CCC(=O)O)C)/C=C\2/C3=CC=CC=C3NC2=O
Canonical SMILES
Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O

名称与同义词

  • Orantinib
  • TSU-68
  • Orantinibum
  • (Z)-Orantinib
  • 252916-29-3
  • Orantinib [INN]
  • SU-6668
  • SU6668
  • 210644-62-5
  • TSU 68
  • SU 6668
  • Orantinib (SU6668)
  • Orantinib (TSU-68)
  • Orantinib; SU-6668
  • RefChem:928252
  • Rosiglitazone + metformin
  • TSU68
  • Orantinib (TSU-68)?
  • MFCD09743433
  • D0A1AQ
  • D0A1ZQ
  • UNII-9RL37ZZ665
  • AC1NS62A
  • ORANTINIB [WHO-DD]
  • CHEMBL274654
  • 9RL37ZZ665
  • cc-447
  • MLS006011090
  • NSC-702827
  • SCHEMBL134661
  • SU006668
  • BDBM4811
  • C18H18N2O3
  • DTXSID101017164
  • GTPL7816
  • orb1301001
  • orb1908974
  • TUS-68
  • NSC 702827
  • SCHEMBL26193119
  • SCHEMBL29354645
  • CHEBI:91088
  • TSU-68 (Random Configuration)
  • TSU-68 (SU6668, Orantinib)
  • TSU-68,SU6668,Orantinib)
  • EX-A471
  • SU-006668
  • SYN1085
  • NHFDRBXTEDBWCZ-ZROIWOOFSA-N
  • BCPP000059
  • HMS3413J06
  • HMS3677J06
  • AOB87351
  • ZINC3834032
  • Orantinib (TSU-68, SU6668)
  • (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
  • ABP000880
  • MFCD03426212
  • NSC702827
  • NSC763929
  • NSC800809
  • RS0104
  • s1470
  • TSU-68 (SU6668)
  • TSU-68 - SU6668
  • AKOS024457561
  • C18-H18-N2-O3
  • (Z)-SU6668
  • CCG-267578
  • CID5329099
  • CS-0197
  • DB12072
  • NSC-763929
  • NSC-800809
  • SDCCGSBI-0654277.P002
  • SU-6597
  • CID:5329099
  • NCGC00387029-01
  • 4CA-1186
  • AC-25028
  • AS-16238
  • BC659953
  • BT162331
  • HY-10517
  • SID:53787898
  • SMR004702878
  • SY240260
  • 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
  • PDGFR Tyrosine Kinase Inhibitor VI, SU6668
  • Pdgfr tyrosine kinase inhibitor vi,su6668
  • AB0033762
  • RT-014974
  • NS00069381
  • ST24036518
  • ST24041377
  • SU-6668(TSU-68)/SU6668
  • SW219790-1
  • X7490
  • EC-000.2125
  • J1.250.198F
  • J1.373.758D
  • A10953
  • A25512
  • W-5401
  • 3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
  • 1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
  • 3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
  • 3-(4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl)-2-indolinone
  • 5-((1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
  • A879274
  • C412603
  • 2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid
  • 3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid
  • 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
  • BRD-K55966568-001-01-3
  • BRD-K55966568-001-05-4
  • BRD-K55966568-001-06-2
  • BRD-K55966568-001-09-6
  • Q27088210
  • TSU68, SU6668, 252916-29-3
  • 1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
  • 1H-Pyrrole-3-propanoicacid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
  • B0084-409435
  • 3-{2,4-Dimethyl-5-[(Z)-(2-Oxo-1,2-Dihydro-3h-Indol-3-Ylidene)methyl]-1h-Pyrrol-3-Yl}propanoic Acid
  • (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid
  • 3-[2,4-dimethyl-5-[(Z)-(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
  • PDGFR Tyrosine Kinase Inhibitor VI, SU6668 - CAS 210644-62-5
  • (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid
  • (Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
  • 1044712-39-1
  • 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
  • (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoicacid
  • 2,4-Dimethyl-5-(2-oxoindoline-3-ylidenemethyl)-1H-pyrrole-3-propionic acid
  • 2,4-Dimethyl-5-[(2-oxoindoline-3-ylidene)methyl]-1H-pyrrole-3-propanoic acid
  • 3-(2,4-dimethyl-5-((Z)-(2-oxo-1H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
  • 3-[2,4-dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1h-pyrrol-3-yl]propionic acid
  • 3-[2,4-dimethyl-5-[(2-oxoindolin-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
  • 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
  • 5-(2-Oxo-2,3-dihydro-1H-indole-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-propionic acid
  • 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid
  • (z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1h-pyrrol-3-yl]-propionic acid
  • 122320-73-4
  • 1H-Pyrrole-3-propanoic acid, 5-((Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
  • 2,4-Dimethyl-5-[(Z)-[2,3-dihydro-2-oxo-1H-indole]-3-ylidenemethyl]-1H-pyrrole-3-propanoic acid
  • 245036-27-5
  • 3-(2,4-DIMETHYL-5-(((3Z)-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID
  • 3-(2,4-dimethyl-5-(((3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
  • 3-[2,4-Dimethyl-5-[[(Z)-2,3-dihydro-2-oxo-1H-indole-3-ylidene]methyl]-1H-pyrrole-3-yl]propanoic acid
  • 3-[2-[(2,3-Dihydro-2-oxo-1H-indole-3-ylidene)methyl]-3,5-dimethyl-1H-pyrrole-4-yl]propanoic acid
  • 3-{2,4-dimethyl-5-[(2-oxo(1H-benzo[d]azolidin-3-ylidene))-methyl]pyrrol-3-yl}propanoic acid
  • 3-{2,4-dimethyl-5-[(2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
  • 5-((Z)-1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
  • SU6
  • TSU-68; 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic Acid; 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone; 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; NSC 702827; Orantinib; SU 6668;